These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 27663144

  • 1. Expression of SOX10, ABCB5 and CD271 in melanocytic lesions and correlation with survival data of patients with melanoma.
    Gambichler T, Petig AL, Stockfleth E, Stücker M.
    Clin Exp Dermatol; 2016 Oct; 41(7):709-16. PubMed ID: 27663144
    [Abstract] [Full Text] [Related]

  • 2. Tumor stem cells (CD271, c-kit, SOX10) in Melanomas: prognostic and outcome implications.
    Mohamed A, Gonzalez RS, Lawson D, Wang J, Cohen C.
    Appl Immunohistochem Mol Morphol; 2014 Oct; 22(2):142-5. PubMed ID: 23958542
    [Abstract] [Full Text] [Related]

  • 3. Sox10 is expressed in primary melanocytic neoplasms of various histologies but not in fibrohistiocytic proliferations and histiocytoses.
    Shin J, Vincent JG, Cuda JD, Xu H, Kang S, Kim J, Taube JM.
    J Am Acad Dermatol; 2012 Oct; 67(4):717-26. PubMed ID: 22325460
    [Abstract] [Full Text] [Related]

  • 4. Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions.
    Massi D, Franchi A, Sardi I, Magnelli L, Paglierani M, Borgognoni L, Maria Reali U, Santucci M.
    J Pathol; 2001 Jun; 194(2):194-200. PubMed ID: 11400148
    [Abstract] [Full Text] [Related]

  • 5. Prognostic significance of cytoplasmic p27 expression in human melanoma.
    Chen G, Cheng Y, Zhang Z, Martinka M, Li G.
    Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2212-21. PubMed ID: 21828232
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Micro-anatomy related antigen expression in melanocytic lesions.
    Meije CB, Mooi WJ, Le Poole IC, Van Muijen GN, Das PK.
    J Pathol; 2000 Apr; 190(5):572-8. PubMed ID: 10727983
    [Abstract] [Full Text] [Related]

  • 8. Moesin and CD44 expression in cutaneous melanocytic tumours.
    Ichikawa T, Masumoto J, Kaneko M, Saida T, Sagara J, Taniguchi S.
    Br J Dermatol; 1998 May; 138(5):763-8. PubMed ID: 9666819
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. An analysis of p16 protein expression in sporadic malignant melanoma.
    Grover R, Chana JS, Wilson GD, Richman PI, Sanders R.
    Melanoma Res; 1998 Jun; 8(3):267-72. PubMed ID: 9664149
    [Abstract] [Full Text] [Related]

  • 12. Nestin and SOX9 and SOX10 transcription factors are coexpressed in melanoma.
    Bakos RM, Maier T, Besch R, Mestel DS, Ruzicka T, Sturm RA, Berking C.
    Exp Dermatol; 2010 Aug; 19(8):e89-94. PubMed ID: 19845757
    [Abstract] [Full Text] [Related]

  • 13. SOX10 Immunostaining in granulomatous dermatoses and benign reactive lymph nodes.
    Merelo Alcocer V, Flamm A, Chen G, Helm K.
    J Cutan Pathol; 2019 Aug; 46(8):586-590. PubMed ID: 30957251
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Melanoma inhibitor of apoptosis protein is expressed differentially in melanoma and melanocytic naevus, but similarly in primary and metastatic melanomas.
    Gong J, Chen N, Zhou Q, Yang B, Wang Y, Wang X.
    J Clin Pathol; 2005 Oct; 58(10):1081-5. PubMed ID: 16189155
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. SOX10 is as specific as S100 protein in detecting metastases of melanoma in lymph nodes and is recommended for sentinel lymph node assessment.
    Szumera-Ciećkiewicz A, Bosisio F, Teterycz P, Antoranz A, Delogu F, Koljenović S, van de Wiel BA, Blokx W, van Kempen LC, Rutkowski P, Christopher van Akkooi A, Cook M, Massi D, EORTC Melanoma Group.
    Eur J Cancer; 2020 Sep; 137():175-182. PubMed ID: 32781392
    [Abstract] [Full Text] [Related]

  • 18. Diagnostic performance of melanocytic markers for immunocytochemical evaluation of lymph-node melanoma metastases on cytological samples.
    Ronchi A, Zito Marino F, Toni G, Pagliuca F, Russo D, Signoriello G, Moscarella E, Brancaccio G, Argenziano G, Franco R, Cozzolino I.
    J Clin Pathol; 2022 Jan; 75(1):45-49. PubMed ID: 33509946
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. VEGF and VEGFR-2 immunohistochemistry in human melanocytic naevi and cutaneous melanomas.
    Pisacane AM, Risio M.
    Melanoma Res; 2005 Feb; 15(1):39-43. PubMed ID: 15714119
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.